Cancer Services Sector: Growth Drivers and Challenges
Growth Drivers
- Higher Prevalence of Cancer
- Growing Technologies for the Treatment and Prevention of Cancer
- Increasing Healthcare Expenditure
Challenges
- Requirement for High Initial Investment
Cancer Services Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
20.4% |
|
Base Year Market Size (2024) |
#N/A |
|
Forecast Year Market Size (2037) |
#N/A |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Cancer Services Market size is poised to grow at over 20.4% CAGR during the forecast period i.e., between 2025-2037.
Increasing cases of cancer, a rising geriatric population, and growing consumption of alcohol, cigarettes, and tobacco will boost the market growth.
North America industry is poised to account for largest revenue share by 2037, impelled by higher prevalence of cancer, developing technologies for the treatment and prevention of cancer, and growing healthcare expenditure.
The major players in the market are Siemens Healthcare GmbH, Fonar Corporation, Koninklijke Philips N.V., Shimadzu Corporation, Abbott Laboratories, Samsung Medison Co., Ltd., Eli Lilly and Company, Hologic, Inc., Novartis International AG, and GE Group.
